AMA005 / Amarna Therap - LARVOL DELTA

Amarna Therapeutics secures additional €5 ($5.7) million to advance its transformative gene therapy platform towards clinical trials (PRNewswire) - "Amarna Therapeutics...announced that it has secured a further €4 million from existing investors C4 holding BV and Flerie Invest AB, as well as € 1 million of additional innovation credit funding from RVO, the Netherlands Enterprise Agency. The funds will enable Amarna to advance its lead gene therapy for the treatment of hemophilia B towards a first-in-human clinical trial, and to progress its R&D pipeline in selected autoimmune diseases and chronic inflammation."

Financing • Hemophilia